News for 'lilly'

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Djokovic says Serena Williams could make a comeback at Wimbledon

Djokovic says Serena Williams could make a comeback at Wimbledon

Rediff.com4 days ago

Novak Djokovic suggested that Serena Williams could see Wimbledon as the ideal venue to return to tennis.

Rare-Disease, Cancer Drugs Get Cheaper

Rare-Disease, Cancer Drugs Get Cheaper

Rediff.com3 Feb 2026

For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.

Biocon launches diabetes & obesity drugs in Netherlands

Biocon launches diabetes & obesity drugs in Netherlands

Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.

Weightloss Drugs Hit 1,000 Crore Mark

Weightloss Drugs Hit 1,000 Crore Mark

Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'

Emcure sets sights on pan-Indian obesity market with Poviztra

Emcure sets sights on pan-Indian obesity market with Poviztra

Rediff.com23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.

'14+ Anti-Obesity Drugs In The Pipeline'

'14+ Anti-Obesity Drugs In The Pipeline'

Rediff.com13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

Priyanka, Kriti, Lilly Have Nailed This Trend...

Priyanka, Kriti, Lilly Have Nailed This Trend...

Rediff.com20 Jan 2025

Stars are taking the talon fashion to a whole new level!

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Rediff.com8 Oct 2025

The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.

Serena Williams shocks fans with 31-pound makeover

Serena Williams shocks fans with 31-pound makeover

Rediff.com22 Aug 2025

The 23-time Grand Slam champion, who retired from professional tennis in 2022, will headline a multi-year national marketing campaign for GLP-1 drugs, a company spokesperson said.

Weight-Loss Drug Battle Intensifies

Weight-Loss Drug Battle Intensifies

Rediff.com22 Jul 2025

'Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five times what it was five years ago.'

'I Don't Want To Box Myself'

'I Don't Want To Box Myself'

Rediff.com21 Aug 2025

'Even though I'm just 31, I feel like I've seen a lot in my life, some voluntarily, some involuntarily.'

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

'Where's Your Bike?' Amiss and the First Cricket Helmet

'Where's Your Bike?' Amiss and the First Cricket Helmet

Rediff.com20 Jul 2025

'I thought helmets would help. So, I took a motorcycle helmet with a polycarbonate visor to WSC.'

Mounjaro, weight-loss, type 2 diabetes drug, launched in India

Mounjaro, weight-loss, type 2 diabetes drug, launched in India

Rediff.com20 Mar 2025

Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

Priyanka's Night Out with Lilly and Diljit!

Priyanka's Night Out with Lilly and Diljit!

Rediff.com29 Jul 2022

Priyanka Chopra had a 'much-needed super fun' outing when she attended a Diljit Dosanjh concert in Los Angeles.

Oh My! When Kiara, Janhvi's Eyes Do The Talking

Oh My! When Kiara, Janhvi's Eyes Do The Talking

Rediff.com20 Feb 2025

Don't shy away from the bold graphic eyeliner!

#IStandWithFarmers: Lilly's bold message at Grammys

#IStandWithFarmers: Lilly's bold message at Grammys

Rediff.com15 Mar 2021

The 32 year old Indo-Canadian YouTube star wore a mask to express her solidarity for the farmers in India.

Kerala leader MA Baby elected CPM chief, first from minority group

Kerala leader MA Baby elected CPM chief, first from minority group

Rediff.com6 Apr 2025

Former Kerala minister M A Baby was elected as the CPI(M) general secretary at the 24th party congress in Madurai. Baby, who was a member of the Rajya Sabha from 1986 to 1998, has been a member of the Politburo since 2012. He succeeds Sitaram Yechury, who passed away last year.

Krishna claims gold as Indian boxers impress at U19 World Championships

Krishna claims gold as Indian boxers impress at U19 World Championships

Rediff.com2 Nov 2024

Young Indian boxer Krisha Verma won the gold in the women's 75kg category while five other signed off with silver medals at the inaugural U-19 World Championships organised by World Boxing in Colorado, USA.

Bisexual and happy! Lilly Singh is embracing her superpower

Bisexual and happy! Lilly Singh is embracing her superpower

Rediff.com27 Feb 2019

In an Instagram post, the Instagram sensation revealed that she is bisexual.

Eli Lilly plans alliances

Eli Lilly plans alliances

Rediff.com30 May 2007

The US-based drug maker Eli Lilly and Company will form strategic drug manufacturing and development alliances with major Indian pharmaceutical companies to tap the opportunities in contract research and manufacturing.

Lilly Singh: From 'Superwoman' to goodwill ambassador

Lilly Singh: From 'Superwoman' to goodwill ambassador

Rediff.com19 Jul 2017

The Indian-origin Canadian YouTube star joins the long list of celebs using their fame to promote a good cause.

Reddy's-Lilly legal battle on

Reddy's-Lilly legal battle on

Rediff.com8 Feb 2003

Lilly Singh turns up the heat in Vogue photo shoot

Lilly Singh turns up the heat in Vogue photo shoot

Rediff.com14 Nov 2019

YouTube sensation Lilly Singh gets you in the mood for winter with her latest cover for Vogue.

Eli Lilly unveils Viagra variant

Eli Lilly unveils Viagra variant

Rediff.com29 Mar 2004

Eli Lilly files suit against Lupin, Aurobindo

Eli Lilly files suit against Lupin, Aurobindo

Rediff.com3 Dec 2008

US-based pharma giants Eli Lilly and company has filed a case against two Indian drug makers, Aurobindo Pharma and Lupin alleging infringement of patent of its anti-depressant drug Cymbalta.

Eli Lilly sues Sun Pharma over patent

Eli Lilly sues Sun Pharma over patent

Rediff.com2 Apr 2007

Eli Lilly and Company, the US-based multinational pharmaceutical major, has sued Sun Pharmaceuticals in the US, alleging the company infringed its patent on Gemzar, a blockbuster cancer drug.

Eli Lilly scouts for R&D tie-ups

Eli Lilly scouts for R&D tie-ups

Rediff.com13 Oct 2005

Nicholas Piramal to develop Eli Lilly products

Nicholas Piramal to develop Eli Lilly products

Rediff.com12 Jan 2007

Pharma major Nicholas Piramal India Ltd will develop and commercialise a select group of US-based Eli Lilly and Company's pre-clinical drug products that span multiple therapeutic areas.

Eli Lilly plans five launches in India

Eli Lilly plans five launches in India

Rediff.com29 May 2007

Global pharmaceutical major Eli Lilly is exploring the possibility of introducing more products from its global portfolio in India.

TCS wins BPO deal from Eli Lilly

TCS wins BPO deal from Eli Lilly

Rediff.com15 Nov 2006

India's largest IT services firm Tata Consultancy Services on Wednesday said it won a contract from Eli Lilly to provide various drug development services to the US pharma firm.

Eli Lilly drug patent deflated

Eli Lilly drug patent deflated

Rediff.com14 Dec 2007

In another setback to Big Pharma, US drug major Eli Lilly's blockbuster erectile dysfunction drug Cialis (generic name:Tadalafil) has failed to qualify for a product patent in India after the basic constituent of the medicine was found to be a known substance, developed and patented by Indian scientists 32 years ago.

Eli Lilly cuts Xigris price by 40%

Eli Lilly cuts Xigris price by 40%

Rediff.com4 Feb 2004

Delhi-based Eli Lilly & Company (India) Pvt Ltd has cut by 40 per cent the price of 'Xigris,' used for treating food poisoning in line with reduced customs duty.

Eli Lilly to discontinue animal insulin product

Eli Lilly to discontinue animal insulin product

Rediff.com3 Jan 2003

Drug major Eli Lilly will discontinue its animal insulin product "Iletin" after this year and is planning to conduct trials for "inhaled insulin" in the country.

Novartis-GSK-Eli Lilly deal may affect Indian market

Novartis-GSK-Eli Lilly deal may affect Indian market

Rediff.com23 Apr 2014

On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.

Modi urges global tech CEOs to be part of India growth story

Modi urges global tech CEOs to be part of India growth story

Rediff.com23 Sep 2024

Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third term. India is currently the fifth largest economy of the world after the US, China, Germany and Japan with a GDP of around $3.9 trillion. India has been the fastest growing large economies of the world with GDP growth rate of over 7 per cent for the last three consecutive years.